Cardinal Health, a Dublin, Ohio-based healthcare giant, has been making waves in the market with its impressive stock performance. The company, which manufactures and distributes pharmaceuticals and medical products globally, has seen its stock, ticker symbol C A H, significantly outperform the broader market this year and over the past twelve months.A recent surge of over fifteen percent in a single trading session followed the release of strong first-quarter results, which showed solid organic growth and notable contributions from recent acquisitions. The companys top-line revenue jumped by twenty-two point four percent year-over-year, reaching sixty-four billion dollars, and adjusted earnings per share surged by thirty-five point six percent year-over-year to two dollars and fifty-five cents.Analysts are optimistic about Cardinal Healths future, expecting adjusted earnings per share of nine dollars and ninety-two cents for the full fiscal year two thousand twenty-six, a twenty point four percent increase from the previous year. The company has a strong track record of beating earnings expectations, having surpassed them in each of the past four quarters.Investment analysts are largely bullish on Cardinal Health, with a consensus rating of Strong Buy. Wells Fargo analyst Stephen Baxter recently maintained an Overweight rating and raised his price target to two hundred twenty-one dollars, indicating continued confidence in the companys trajectory.

The Daily News Now! — Every city. Every story. AI-powered.

---

Hosted on Acast. See acast.com/privacy for more information.